This Week in Nature

In an editorial, Nature announces that they will be introducing a creative commons license for the reuse of papers reporting full genome sequences. Under this license, non-commercial publishers may reuse the pdf and html versions of the article and other users may copy, distribute, and/or adapt the paper for non-commercial uses. This continues, the editors write, "[Nature's] drive to make papers as accessible as possible."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.